BioCryst Pharmaceuticals (BCRX) Short Interest Ratio & Short Volume $7.60 +0.11 (+1.47%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BioCryst Pharmaceuticals Short Interest DataBioCryst Pharmaceuticals (BCRX) has a short interest of 20.83 million shares. This marks a -7.55% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.7, indicating that it would take 10.7 days of the average trading volume of 2.92 million shares to cover all short positions.Current Short Interest20,830,000 sharesPrevious Short Interest22,530,000 sharesChange Vs. Previous Month-7.55%Dollar Volume Sold Short$166.85 millionShort Interest Ratio10.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares207,133,000 sharesPercentage of Shares Shorted10.06%Today's Trading Volume1,967,385 sharesAverage Trading Volume2,922,620 sharesToday's Volume Vs. Average67% Short Selling BioCryst Pharmaceuticals? Sign up to receive the latest short interest report for BioCryst Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCRX Short Interest Over TimeBCRX Days to Cover Over TimeBCRX Percentage of Float Shorted Over Time Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now BioCryst Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202420,830,000 shares $166.85 million -7.6%N/A10.7 $8.01 10/15/202422,530,000 shares $168.52 million -3.0%N/A11.4 $7.48 9/30/202423,230,000 shares $176.55 million -4.5%N/A10.8 $7.60 9/15/202424,320,000 shares $192.61 million +1.1%N/A10.3 $7.92 8/31/202424,060,000 shares $209.08 million -3.0%N/A8.9 $8.69 8/15/202424,810,000 shares $189.30 million +1.8%N/A8.2 $7.63 Get the Latest News and Ratings for BCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCryst Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202424,380,000 shares $177.49 million +11.8%N/A7.1 $7.28 7/15/202421,810,000 shares $156.60 million +22.0%N/A6 $7.18 6/30/202417,880,000 shares $110.50 million -39.7%N/A5 $6.18 6/15/202429,670,000 shares $183.06 million -18.0%N/A8.1 $6.17 5/31/202436,180,000 shares $233.72 million +5.3%N/A9.9 $6.46 5/15/202434,350,000 shares $218.47 million +2.1%N/A9.5 $6.36 4/30/202433,640,000 shares $138.93 million -2.2%N/A9.9 $4.13 4/15/202434,390,000 shares $160.60 million +6.6%N/A11 $4.67 3/31/202432,250,000 shares $163.83 million +5.6%N/A9.8 $5.08 3/15/202430,550,000 shares $152.75 million +5.0%N/A9.3 $5.00 2/29/202429,100,000 shares $163.83 million -1.1%N/A7.4 $5.63 2/15/202429,410,000 shares $165.87 million +1.3%N/A7.6 $5.64 1/31/202429,040,000 shares $153.91 million +3.5%N/A7.6 $5.30 1/15/202428,050,000 shares $178.12 million -6.8%N/A7.1 $6.35 12/31/202330,080,000 shares $180.18 million +1.0%N/A7.4 $5.99 12/15/202329,780,000 shares $184.34 million +1.4%N/A7.8 $6.19 11/30/202329,380,000 shares $172.75 million -0.3%N/A8.5 $5.88 11/15/202329,470,000 shares $153.54 million -2.2%N/A10.3 $5.21 10/31/202330,130,000 shares $165.41 million -31.8%N/A10.9 $5.49 10/15/202344,190,000 shares $262.49 million +4.3%N/A15.5 $5.94 9/30/202342,390,000 shares $300.12 million -0.3%N/A17 $7.08 9/15/202342,500,000 shares $291.13 million +2.9%N/A16.9 $6.85 8/31/202341,300,000 shares $293.64 million +3.1%N/A16.3 $7.11 8/15/202340,060,000 shares $278.02 million +2.7%N/A15.2 $6.94 7/31/202339,000,000 shares $288.21 million +3.4%N/A14.7 $7.39 7/15/202337,730,000 shares $269.01 million +0.9%N/A14.9 $7.13 6/30/202337,390,000 shares $263.23 million +5.4%N/A13.8 $7.04 6/15/202335,480,000 shares $283.13 million -0.3%N/A12.9 $7.98 5/31/202335,580,000 shares $294.25 million +10.2%N/A13 $8.27 5/15/202332,300,000 shares $283.27 million +3.5%N/A11 $8.77 4/30/202331,200,000 shares $237.43 million +2.8%N/A10.2 $7.61 4/15/202330,360,000 shares $245.01 million -2.8%N/A10.5 $8.07 3/31/202331,220,000 shares $260.37 million +1.3%N/A10.7 $8.34 3/15/202330,810,000 shares $257.88 million +4.5%N/A10.3 $8.37[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin 2/28/202329,480,000 shares $260.90 million +9.2%N/A9.9 $8.85 2/15/202326,990,000 shares $274.22 million +1.2%N/A9.7 $10.16 1/31/202326,680,000 shares $281.47 million +2.2%N/A10.2 $10.55 1/15/202326,110,000 shares $265.28 million -4.2%N/A8.8 $10.16 12/30/202227,240,000 shares $312.72 million -1.6%N/A9.6 $11.48 12/15/202227,680,000 shares $299.22 million +0.3%N/A10.3 $10.81 11/30/202227,610,000 shares $368.87 million -0.9%N/A10.3 $13.36 11/15/202227,870,000 shares $369.00 million +0.9%N/A10.7 $13.24 10/31/202227,630,000 shares $368.86 million -2.3%N/A10.5 $13.35 10/15/202228,290,000 shares $382.76 million +0.6%N/A11 $13.53 9/30/202228,130,000 shares $354.44 million -2.4%N/A10.9 $12.60 9/15/202228,820,000 shares $369.76 million +3.3%N/A10.5 $12.83 8/31/202227,910,000 shares $387.95 million +2.1%N/A9.7 $13.90 8/15/202227,350,000 shares $405.05 million -7.9%N/A9.1 $14.81 7/31/202229,680,000 shares $327.07 million -5.7%N/A8.7 $11.02 7/15/202231,460,000 shares $366.51 million +0.5%N/A8.5 $11.65 6/30/202231,300,000 shares $331.15 million +5.4%N/A6.4 $10.58 6/15/202229,690,000 shares $276.12 million +0.5%N/A6.2 $9.30 5/31/202229,550,000 shares $275.11 million -0.3%N/A6.3 $9.31 5/15/202229,650,000 shares $248.76 million -3.4%N/A6.1 $8.39 4/30/202230,690,000 shares $285.11 million +7.5%N/A6.4 $9.29 4/15/202228,550,000 shares $325.18 million +11.7%N/A6.5 $11.39 3/31/202225,570,000 shares $415.77 million -5.4%N/A5.6 $16.26 3/15/202227,030,000 shares $409.77 million +2.0%N/A6.9 $15.16 2/28/202226,500,000 shares $440.17 million +2.6%N/A7 $16.61 2/15/202225,820,000 shares $484.38 million +3.2%14.7%6.9 $18.76 1/31/202225,020,000 shares $386.56 million -1.8%14.1%7.1 $15.45 1/15/202225,470,000 shares $394.28 million -2.3%14.4%7 $15.48 12/31/202126,080,000 shares $361.21 million +6.3%14.8%8 $13.85 12/15/202124,540,000 shares $291.29 million +1.5%14.0%8.7 $11.87 11/30/202124,180,000 shares $291.61 million +7.2%13.7%8.9 $12.06 11/15/202122,550,000 shares $267.67 million +10.4%12.7%8.6 $11.87 10/29/202120,420,000 shares $304.87 million +7.6%11.5%7.4 $14.93 10/15/202118,970,000 shares $287.02 million +2.3%10.7%7.2 $15.13 9/30/202118,540,000 shares $266.42 million -2.3%10.5%6.9 $14.37 9/15/202118,980,000 shares $286.03 million -1.6%10.7%6.8 $15.07 8/31/202119,290,000 shares $307.10 million -6.1%10.9%6.5 $15.92 8/13/202120,540,000 shares $331.72 million +11.9%11.6%6.4 $16.15 7/30/202118,350,000 shares $295.80 million -0.1%10.5%5.4 $16.12 7/15/202118,370,000 shares $290.25 million -4.1%10.5%5.3 $15.80 6/30/202119,150,000 shares $302.76 million -2.0%10.9%5.2 $15.81 6/15/202119,530,000 shares $304.86 million -2.4%11.1%5.1 $15.61 5/28/202120,010,000 shares $315.56 million -9.6%11.4%4.3 $15.77 5/14/202122,130,000 shares $264.67 million -3.6%N/A4.3 $11.96 4/30/202122,950,000 shares $278.15 million -8.1%N/A4.1 $12.12 4/15/202124,980,000 shares $254.55 million +7.0%N/A3.7 $10.19 3/31/202123,350,000 shares $233.27 million -12.5%N/A3.3 $9.99 3/15/202126,680,000 shares $337.24 million -7.8%N/A3.5 $12.64 2/26/202128,920,000 shares $302.79 million +0.2%N/A3.5 $10.47 2/12/202128,860,000 shares $265.51 million -8.5%N/A3.5 $9.20[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin 1/29/202131,530,000 shares $274.63 million +1.9%N/A4 $8.71 1/15/202130,950,000 shares $265.86 million No ChangeN/A4.6 $8.59 12/31/202030,950,000 shares $232.13 million -16.4%N/A4.7 $7.50 12/15/202037,040,000 shares $314.84 million -1.0%N/A5.5 $8.50 11/30/202037,420,000 shares $191.96 million -1.7%N/A6.2 $5.13 11/15/202038,070,000 shares $167.89 million -7.9%N/A7.6 $4.41 10/30/202041,320,000 shares $154.12 million +8.5%N/A8.1 $3.73 10/15/202038,100,000 shares $147.83 million +4.7%N/A6.8 $3.88 9/30/202036,390,000 shares $125.00 million +5.0%N/A6.2 $3.44 9/15/202034,650,000 shares $138.60 million +3.3%N/A5.3 $4.00 8/31/202033,560,000 shares $139.27 million -11.7%N/A4.8 $4.15 8/14/202038,010,000 shares $163.44 million +11.8%N/A5.2 $4.30 7/31/202034,000,000 shares $138.38 million +9.3%N/A4.1 $4.07 7/15/202031,100,000 shares $162.50 million -3.1%N/A3.2 $5.23 6/30/202032,100,000 shares $152.96 million +55.6%N/A2.9 $4.77 6/15/202020,630,000 shares $92.63 million +11.9%N/A2 $4.49 5/29/202018,430,000 shares $82.75 million +8.0%N/A1.7 $4.49 5/15/202017,070,000 shares $90.30 million -4.6%N/A1.6 $5.29 4/30/202017,890,000 shares $69.95 million +1.5%N/A1.9 $3.91 4/15/202017,630,000 shares $47.60 million +11.2%N/A2.3 $2.70 3/31/202015,860,000 shares $56.46 million -1.2%N/A2.8 $3.56 3/13/202016,053,900 shares $33.23 million +7.5%N/A1.6 $2.07 2/28/202014,940,000 shares $29.28 million -2.3%N/A3.3 $1.96 2/14/202015,290,000 shares $42.96 million -4.7%N/A4.5 $2.81 1/31/202016,050,000 shares $40.61 million -0.6%N/A4.3 $2.53 1/15/202016,140,000 shares $46.81 million -10.3%N/A4.6 $2.90 12/31/201918,000,000 shares $50.58 million +31.4%N/A6.4 $2.81 BCRX Short Interest - Frequently Asked Questions What is BioCryst Pharmaceuticals' current short interest? Short interest is the volume of BioCryst Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 20,830,000 shares of BCRX short. Learn More on BioCryst Pharmaceuticals' current short interest. What is a good short interest ratio for BioCryst Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCRX shares currently have a short interest ratio of 11.0. Learn More on BioCryst Pharmaceuticals's short interest ratio. Which institutional investors are shorting BioCryst Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioCryst Pharmaceuticals: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioCryst Pharmaceuticals' short interest increasing or decreasing? BioCryst Pharmaceuticals saw a decline in short interest in October. As of October 31st, there was short interest totaling 20,830,000 shares, a decline of 7.5% from the previous total of 22,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioCryst Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to BioCryst Pharmaceuticals: Taysha Gene Therapies, Inc. (8.61%), Adaptimmune Therapeutics plc (2.09%), Vaxart, Inc. (4.95%), Aligos Therapeutics, Inc. (4.78%), Passage Bio, Inc. (3.21%), Krystal Biotech, Inc. (12.00%), Halozyme Therapeutics, Inc. (8.14%), Ionis Pharmaceuticals, Inc. (7.37%), Alkermes plc (10.15%), Amicus Therapeutics, Inc. (6.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short BioCryst Pharmaceuticals stock? Short selling BCRX is an investing strategy that aims to generate trading profit from BioCryst Pharmaceuticals as its price is falling. BCRX shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCryst Pharmaceuticals? A short squeeze for BioCryst Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCRX, which in turn drives the price of the stock up even further. How often is BioCryst Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCRX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies TSHA Short Interest ADAP Short Interest VXRT Short Interest ALGS Short Interest PASG Short Interest KRYS Short Interest HALO Short Interest IONS Short Interest ALKS Short Interest FOLD Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCRX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCryst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCryst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCRX Stock Alerts